PatentsGlobal
American Fusion Inc. (OTCQB: AMFN) has filed 21 additional U.S. patent applications for its Texatron™ fusion platform, increasing its pending portfolio to 151. The company is progressing with testing at a university lab while negotiating acquisition terms for a dedicated testing facility. Concurrently, American Fusion…
Tuesday, September 22, 2026
PatentsGlobal
Vector Science & Therapeutics Corp. has expanded its intellectual property holdings to include 15 patent applications filed over the past two years. These applications cover a wide array of technologies aimed at enhancing precision delivery of therapeutic agents, particularly peptides and biologics, via non-invasive,…
Wednesday, July 15, 2026
PatentsGlobal
Vector Science & Therapeutics has developed a comprehensive intellectual property portfolio comprising 15 patent applications over two years. The portfolio centers on innovative delivery systems for peptides and biologics, addressing challenges in targeted therapeutic administration across pain management, oncology, r…
Wednesday, July 15, 2026